Global Aprepitant Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
LPI (LP Information)' newest research report, the “Aprepitant Industry Forecast” looks at past sales and reviews total world Aprepitant sales in 2022, providing a comprehensive analysis by region and market sector of projected Aprepitant sales for 2023 through 2029. With Aprepitant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aprepitant industry.
This Insight Report provides a comprehensive analysis of the global Aprepitant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aprepitant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aprepitant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aprepitant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aprepitant.
The global Aprepitant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Aprepitant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Aprepitant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Aprepitant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Aprepitant players cover Merck & Co., Heron Therapeutics, Sandoz and Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Aprepitant market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Aprepitant market?
What factors are driving Aprepitant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aprepitant market opportunities vary by end market size?
How does Aprepitant break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
LPI (LP Information)' newest research report, the “Aprepitant Industry Forecast” looks at past sales and reviews total world Aprepitant sales in 2022, providing a comprehensive analysis by region and market sector of projected Aprepitant sales for 2023 through 2029. With Aprepitant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aprepitant industry.
This Insight Report provides a comprehensive analysis of the global Aprepitant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aprepitant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aprepitant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aprepitant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aprepitant.
The global Aprepitant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Aprepitant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Aprepitant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Aprepitant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Aprepitant players cover Merck & Co., Heron Therapeutics, Sandoz and Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Aprepitant market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Injection
- Oral
- Hospital
- Drug store
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co.
- Heron Therapeutics
- Sandoz
- Glenmark Pharmaceuticals
What is the 10-year outlook for the global Aprepitant market?
What factors are driving Aprepitant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aprepitant market opportunities vary by end market size?
How does Aprepitant break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aprepitant Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aprepitant by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aprepitant by Country/Region, 2018, 2022 & 2029
2.2 Aprepitant Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Aprepitant Sales by Type
2.3.1 Global Aprepitant Sales Market Share by Type (2018-2023)
2.3.2 Global Aprepitant Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aprepitant Sale Price by Type (2018-2023)
2.4 Aprepitant Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Aprepitant Sales by Application
2.5.1 Global Aprepitant Sale Market Share by Application (2018-2023)
2.5.2 Global Aprepitant Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aprepitant Sale Price by Application (2018-2023)
3 GLOBAL APREPITANT BY COMPANY
3.1 Global Aprepitant Breakdown Data by Company
3.1.1 Global Aprepitant Annual Sales by Company (2018-2023)
3.1.2 Global Aprepitant Sales Market Share by Company (2018-2023)
3.2 Global Aprepitant Annual Revenue by Company (2018-2023)
3.2.1 Global Aprepitant Revenue by Company (2018-2023)
3.2.2 Global Aprepitant Revenue Market Share by Company (2018-2023)
3.3 Global Aprepitant Sale Price by Company
3.4 Key Manufacturers Aprepitant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aprepitant Product Location Distribution
3.4.2 Players Aprepitant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
4.1 World Historic Aprepitant Market Size by Geographic Region (2018-2023)
4.1.1 Global Aprepitant Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aprepitant Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aprepitant Market Size by Country/Region (2018-2023)
4.2.1 Global Aprepitant Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aprepitant Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aprepitant Sales Growth
4.4 APAC Aprepitant Sales Growth
4.5 Europe Aprepitant Sales Growth
4.6 Middle East & Africa Aprepitant Sales Growth
5 AMERICAS
5.1 Americas Aprepitant Sales by Country
5.1.1 Americas Aprepitant Sales by Country (2018-2023)
5.1.2 Americas Aprepitant Revenue by Country (2018-2023)
5.2 Americas Aprepitant Sales by Type
5.3 Americas Aprepitant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aprepitant Sales by Region
6.1.1 APAC Aprepitant Sales by Region (2018-2023)
6.1.2 APAC Aprepitant Revenue by Region (2018-2023)
6.2 APAC Aprepitant Sales by Type
6.3 APAC Aprepitant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aprepitant by Country
7.1.1 Europe Aprepitant Sales by Country (2018-2023)
7.1.2 Europe Aprepitant Revenue by Country (2018-2023)
7.2 Europe Aprepitant Sales by Type
7.3 Europe Aprepitant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aprepitant by Country
8.1.1 Middle East & Africa Aprepitant Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aprepitant Revenue by Country (2018-2023)
8.2 Middle East & Africa Aprepitant Sales by Type
8.3 Middle East & Africa Aprepitant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aprepitant
10.3 Manufacturing Process Analysis of Aprepitant
10.4 Industry Chain Structure of Aprepitant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aprepitant Distributors
11.3 Aprepitant Customer
12 WORLD FORECAST REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
12.1 Global Aprepitant Market Size Forecast by Region
12.1.1 Global Aprepitant Forecast by Region (2024-2029)
12.1.2 Global Aprepitant Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aprepitant Forecast by Type
12.7 Global Aprepitant Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Aprepitant Product Portfolios and Specifications
13.1.3 Merck & Co. Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Heron Therapeutics
13.2.1 Heron Therapeutics Company Information
13.2.2 Heron Therapeutics Aprepitant Product Portfolios and Specifications
13.2.3 Heron Therapeutics Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Heron Therapeutics Main Business Overview
13.2.5 Heron Therapeutics Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Aprepitant Product Portfolios and Specifications
13.3.3 Sandoz Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aprepitant Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aprepitant by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aprepitant by Country/Region, 2018, 2022 & 2029
2.2 Aprepitant Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Aprepitant Sales by Type
2.3.1 Global Aprepitant Sales Market Share by Type (2018-2023)
2.3.2 Global Aprepitant Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aprepitant Sale Price by Type (2018-2023)
2.4 Aprepitant Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Aprepitant Sales by Application
2.5.1 Global Aprepitant Sale Market Share by Application (2018-2023)
2.5.2 Global Aprepitant Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aprepitant Sale Price by Application (2018-2023)
3 GLOBAL APREPITANT BY COMPANY
3.1 Global Aprepitant Breakdown Data by Company
3.1.1 Global Aprepitant Annual Sales by Company (2018-2023)
3.1.2 Global Aprepitant Sales Market Share by Company (2018-2023)
3.2 Global Aprepitant Annual Revenue by Company (2018-2023)
3.2.1 Global Aprepitant Revenue by Company (2018-2023)
3.2.2 Global Aprepitant Revenue Market Share by Company (2018-2023)
3.3 Global Aprepitant Sale Price by Company
3.4 Key Manufacturers Aprepitant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aprepitant Product Location Distribution
3.4.2 Players Aprepitant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
4.1 World Historic Aprepitant Market Size by Geographic Region (2018-2023)
4.1.1 Global Aprepitant Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aprepitant Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aprepitant Market Size by Country/Region (2018-2023)
4.2.1 Global Aprepitant Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aprepitant Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aprepitant Sales Growth
4.4 APAC Aprepitant Sales Growth
4.5 Europe Aprepitant Sales Growth
4.6 Middle East & Africa Aprepitant Sales Growth
5 AMERICAS
5.1 Americas Aprepitant Sales by Country
5.1.1 Americas Aprepitant Sales by Country (2018-2023)
5.1.2 Americas Aprepitant Revenue by Country (2018-2023)
5.2 Americas Aprepitant Sales by Type
5.3 Americas Aprepitant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aprepitant Sales by Region
6.1.1 APAC Aprepitant Sales by Region (2018-2023)
6.1.2 APAC Aprepitant Revenue by Region (2018-2023)
6.2 APAC Aprepitant Sales by Type
6.3 APAC Aprepitant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aprepitant by Country
7.1.1 Europe Aprepitant Sales by Country (2018-2023)
7.1.2 Europe Aprepitant Revenue by Country (2018-2023)
7.2 Europe Aprepitant Sales by Type
7.3 Europe Aprepitant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aprepitant by Country
8.1.1 Middle East & Africa Aprepitant Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aprepitant Revenue by Country (2018-2023)
8.2 Middle East & Africa Aprepitant Sales by Type
8.3 Middle East & Africa Aprepitant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aprepitant
10.3 Manufacturing Process Analysis of Aprepitant
10.4 Industry Chain Structure of Aprepitant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aprepitant Distributors
11.3 Aprepitant Customer
12 WORLD FORECAST REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
12.1 Global Aprepitant Market Size Forecast by Region
12.1.1 Global Aprepitant Forecast by Region (2024-2029)
12.1.2 Global Aprepitant Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aprepitant Forecast by Type
12.7 Global Aprepitant Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Aprepitant Product Portfolios and Specifications
13.1.3 Merck & Co. Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Heron Therapeutics
13.2.1 Heron Therapeutics Company Information
13.2.2 Heron Therapeutics Aprepitant Product Portfolios and Specifications
13.2.3 Heron Therapeutics Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Heron Therapeutics Main Business Overview
13.2.5 Heron Therapeutics Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Aprepitant Product Portfolios and Specifications
13.3.3 Sandoz Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Aprepitant Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Aprepitant Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Aprepitant Sales by Type (2018-2023) & (K Units)
Table 6. Global Aprepitant Sales Market Share by Type (2018-2023)
Table 7. Global Aprepitant Revenue by Type (2018-2023) & ($ million)
Table 8. Global Aprepitant Revenue Market Share by Type (2018-2023)
Table 9. Global Aprepitant Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Aprepitant Sales by Application (2018-2023) & (K Units)
Table 11. Global Aprepitant Sales Market Share by Application (2018-2023)
Table 12. Global Aprepitant Revenue by Application (2018-2023)
Table 13. Global Aprepitant Revenue Market Share by Application (2018-2023)
Table 14. Global Aprepitant Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Aprepitant Sales by Company (2018-2023) & (K Units)
Table 16. Global Aprepitant Sales Market Share by Company (2018-2023)
Table 17. Global Aprepitant Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Aprepitant Revenue Market Share by Company (2018-2023)
Table 19. Global Aprepitant Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Aprepitant Producing Area Distribution and Sales Area
Table 21. Players Aprepitant Products Offered
Table 22. Aprepitant Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Aprepitant Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Aprepitant Sales Market Share Geographic Region (2018-2023)
Table 27. Global Aprepitant Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Aprepitant Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Aprepitant Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Aprepitant Sales Market Share by Country/Region (2018-2023)
Table 31. Global Aprepitant Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Aprepitant Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Aprepitant Sales by Country (2018-2023) & (K Units)
Table 34. Americas Aprepitant Sales Market Share by Country (2018-2023)
Table 35. Americas Aprepitant Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Aprepitant Revenue Market Share by Country (2018-2023)
Table 37. Americas Aprepitant Sales by Type (2018-2023) & (K Units)
Table 38. Americas Aprepitant Sales by Application (2018-2023) & (K Units)
Table 39. APAC Aprepitant Sales by Region (2018-2023) & (K Units)
Table 40. APAC Aprepitant Sales Market Share by Region (2018-2023)
Table 41. APAC Aprepitant Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Aprepitant Revenue Market Share by Region (2018-2023)
Table 43. APAC Aprepitant Sales by Type (2018-2023) & (K Units)
Table 44. APAC Aprepitant Sales by Application (2018-2023) & (K Units)
Table 45. Europe Aprepitant Sales by Country (2018-2023) & (K Units)
Table 46. Europe Aprepitant Sales Market Share by Country (2018-2023)
Table 47. Europe Aprepitant Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Aprepitant Revenue Market Share by Country (2018-2023)
Table 49. Europe Aprepitant Sales by Type (2018-2023) & (K Units)
Table 50. Europe Aprepitant Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Aprepitant Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Aprepitant Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Aprepitant Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Aprepitant Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Aprepitant Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Aprepitant Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Aprepitant
Table 58. Key Market Challenges & Risks of Aprepitant
Table 59. Key Industry Trends of Aprepitant
Table 60. Aprepitant Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Aprepitant Distributors List
Table 63. Aprepitant Customer List
Table 64. Global Aprepitant Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Aprepitant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Aprepitant Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Aprepitant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Aprepitant Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Aprepitant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Aprepitant Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Aprepitant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Aprepitant Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Aprepitant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Aprepitant Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Aprepitant Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Aprepitant Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Aprepitant Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck & Co. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck & Co. Aprepitant Product Portfolios and Specifications
Table 80. Merck & Co. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Merck & Co. Main Business
Table 82. Merck & Co. Latest Developments
Table 83. Heron Therapeutics Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 84. Heron Therapeutics Aprepitant Product Portfolios and Specifications
Table 85. Heron Therapeutics Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Heron Therapeutics Main Business
Table 87. Heron Therapeutics Latest Developments
Table 88. Sandoz Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 89. Sandoz Aprepitant Product Portfolios and Specifications
Table 90. Sandoz Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Sandoz Main Business
Table 92. Sandoz Latest Developments
Table 93. Glenmark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
Table 95. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Glenmark Pharmaceuticals Main Business
Table 97. Glenmark Pharmaceuticals Latest Developments
Table 1. Aprepitant Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Aprepitant Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Aprepitant Sales by Type (2018-2023) & (K Units)
Table 6. Global Aprepitant Sales Market Share by Type (2018-2023)
Table 7. Global Aprepitant Revenue by Type (2018-2023) & ($ million)
Table 8. Global Aprepitant Revenue Market Share by Type (2018-2023)
Table 9. Global Aprepitant Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Aprepitant Sales by Application (2018-2023) & (K Units)
Table 11. Global Aprepitant Sales Market Share by Application (2018-2023)
Table 12. Global Aprepitant Revenue by Application (2018-2023)
Table 13. Global Aprepitant Revenue Market Share by Application (2018-2023)
Table 14. Global Aprepitant Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Aprepitant Sales by Company (2018-2023) & (K Units)
Table 16. Global Aprepitant Sales Market Share by Company (2018-2023)
Table 17. Global Aprepitant Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Aprepitant Revenue Market Share by Company (2018-2023)
Table 19. Global Aprepitant Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Aprepitant Producing Area Distribution and Sales Area
Table 21. Players Aprepitant Products Offered
Table 22. Aprepitant Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Aprepitant Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Aprepitant Sales Market Share Geographic Region (2018-2023)
Table 27. Global Aprepitant Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Aprepitant Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Aprepitant Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Aprepitant Sales Market Share by Country/Region (2018-2023)
Table 31. Global Aprepitant Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Aprepitant Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Aprepitant Sales by Country (2018-2023) & (K Units)
Table 34. Americas Aprepitant Sales Market Share by Country (2018-2023)
Table 35. Americas Aprepitant Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Aprepitant Revenue Market Share by Country (2018-2023)
Table 37. Americas Aprepitant Sales by Type (2018-2023) & (K Units)
Table 38. Americas Aprepitant Sales by Application (2018-2023) & (K Units)
Table 39. APAC Aprepitant Sales by Region (2018-2023) & (K Units)
Table 40. APAC Aprepitant Sales Market Share by Region (2018-2023)
Table 41. APAC Aprepitant Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Aprepitant Revenue Market Share by Region (2018-2023)
Table 43. APAC Aprepitant Sales by Type (2018-2023) & (K Units)
Table 44. APAC Aprepitant Sales by Application (2018-2023) & (K Units)
Table 45. Europe Aprepitant Sales by Country (2018-2023) & (K Units)
Table 46. Europe Aprepitant Sales Market Share by Country (2018-2023)
Table 47. Europe Aprepitant Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Aprepitant Revenue Market Share by Country (2018-2023)
Table 49. Europe Aprepitant Sales by Type (2018-2023) & (K Units)
Table 50. Europe Aprepitant Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Aprepitant Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Aprepitant Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Aprepitant Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Aprepitant Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Aprepitant Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Aprepitant Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Aprepitant
Table 58. Key Market Challenges & Risks of Aprepitant
Table 59. Key Industry Trends of Aprepitant
Table 60. Aprepitant Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Aprepitant Distributors List
Table 63. Aprepitant Customer List
Table 64. Global Aprepitant Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Aprepitant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Aprepitant Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Aprepitant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Aprepitant Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Aprepitant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Aprepitant Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Aprepitant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Aprepitant Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Aprepitant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Aprepitant Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Aprepitant Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Aprepitant Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Aprepitant Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck & Co. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck & Co. Aprepitant Product Portfolios and Specifications
Table 80. Merck & Co. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Merck & Co. Main Business
Table 82. Merck & Co. Latest Developments
Table 83. Heron Therapeutics Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 84. Heron Therapeutics Aprepitant Product Portfolios and Specifications
Table 85. Heron Therapeutics Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Heron Therapeutics Main Business
Table 87. Heron Therapeutics Latest Developments
Table 88. Sandoz Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 89. Sandoz Aprepitant Product Portfolios and Specifications
Table 90. Sandoz Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Sandoz Main Business
Table 92. Sandoz Latest Developments
Table 93. Glenmark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
Table 95. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Glenmark Pharmaceuticals Main Business
Table 97. Glenmark Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Aprepitant
Figure 2. Aprepitant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aprepitant Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Aprepitant Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Aprepitant Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Aprepitant Sales Market Share by Type in 2022
Figure 12. Global Aprepitant Revenue Market Share by Type (2018-2023)
Figure 13. Aprepitant Consumed in Hospital
Figure 14. Global Aprepitant Market: Hospital (2018-2023) & (K Units)
Figure 15. Aprepitant Consumed in Drug store
Figure 16. Global Aprepitant Market: Drug store (2018-2023) & (K Units)
Figure 17. Global Aprepitant Sales Market Share by Application (2022)
Figure 18. Global Aprepitant Revenue Market Share by Application in 2022
Figure 19. Aprepitant Sales Market by Company in 2022 (K Units)
Figure 20. Global Aprepitant Sales Market Share by Company in 2022
Figure 21. Aprepitant Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Aprepitant Revenue Market Share by Company in 2022
Figure 23. Global Aprepitant Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Aprepitant Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Aprepitant Sales 2018-2023 (K Units)
Figure 26. Americas Aprepitant Revenue 2018-2023 ($ Millions)
Figure 27. APAC Aprepitant Sales 2018-2023 (K Units)
Figure 28. APAC Aprepitant Revenue 2018-2023 ($ Millions)
Figure 29. Europe Aprepitant Sales 2018-2023 (K Units)
Figure 30. Europe Aprepitant Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Aprepitant Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Aprepitant Revenue 2018-2023 ($ Millions)
Figure 33. Americas Aprepitant Sales Market Share by Country in 2022
Figure 34. Americas Aprepitant Revenue Market Share by Country in 2022
Figure 35. Americas Aprepitant Sales Market Share by Type (2018-2023)
Figure 36. Americas Aprepitant Sales Market Share by Application (2018-2023)
Figure 37. United States Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Aprepitant Sales Market Share by Region in 2022
Figure 42. APAC Aprepitant Revenue Market Share by Regions in 2022
Figure 43. APAC Aprepitant Sales Market Share by Type (2018-2023)
Figure 44. APAC Aprepitant Sales Market Share by Application (2018-2023)
Figure 45. China Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Aprepitant Sales Market Share by Country in 2022
Figure 53. Europe Aprepitant Revenue Market Share by Country in 2022
Figure 54. Europe Aprepitant Sales Market Share by Type (2018-2023)
Figure 55. Europe Aprepitant Sales Market Share by Application (2018-2023)
Figure 56. Germany Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Aprepitant Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Aprepitant Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Aprepitant Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Aprepitant Sales Market Share by Application (2018-2023)
Figure 65. Egypt Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Aprepitant in 2022
Figure 71. Manufacturing Process Analysis of Aprepitant
Figure 72. Industry Chain Structure of Aprepitant
Figure 73. Channels of Distribution
Figure 74. Global Aprepitant Sales Market Forecast by Region (2024-2029)
Figure 75. Global Aprepitant Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Aprepitant Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Aprepitant Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Aprepitant Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Aprepitant Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Aprepitant
Figure 2. Aprepitant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aprepitant Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Aprepitant Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Aprepitant Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Aprepitant Sales Market Share by Type in 2022
Figure 12. Global Aprepitant Revenue Market Share by Type (2018-2023)
Figure 13. Aprepitant Consumed in Hospital
Figure 14. Global Aprepitant Market: Hospital (2018-2023) & (K Units)
Figure 15. Aprepitant Consumed in Drug store
Figure 16. Global Aprepitant Market: Drug store (2018-2023) & (K Units)
Figure 17. Global Aprepitant Sales Market Share by Application (2022)
Figure 18. Global Aprepitant Revenue Market Share by Application in 2022
Figure 19. Aprepitant Sales Market by Company in 2022 (K Units)
Figure 20. Global Aprepitant Sales Market Share by Company in 2022
Figure 21. Aprepitant Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Aprepitant Revenue Market Share by Company in 2022
Figure 23. Global Aprepitant Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Aprepitant Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Aprepitant Sales 2018-2023 (K Units)
Figure 26. Americas Aprepitant Revenue 2018-2023 ($ Millions)
Figure 27. APAC Aprepitant Sales 2018-2023 (K Units)
Figure 28. APAC Aprepitant Revenue 2018-2023 ($ Millions)
Figure 29. Europe Aprepitant Sales 2018-2023 (K Units)
Figure 30. Europe Aprepitant Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Aprepitant Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Aprepitant Revenue 2018-2023 ($ Millions)
Figure 33. Americas Aprepitant Sales Market Share by Country in 2022
Figure 34. Americas Aprepitant Revenue Market Share by Country in 2022
Figure 35. Americas Aprepitant Sales Market Share by Type (2018-2023)
Figure 36. Americas Aprepitant Sales Market Share by Application (2018-2023)
Figure 37. United States Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Aprepitant Sales Market Share by Region in 2022
Figure 42. APAC Aprepitant Revenue Market Share by Regions in 2022
Figure 43. APAC Aprepitant Sales Market Share by Type (2018-2023)
Figure 44. APAC Aprepitant Sales Market Share by Application (2018-2023)
Figure 45. China Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Aprepitant Sales Market Share by Country in 2022
Figure 53. Europe Aprepitant Revenue Market Share by Country in 2022
Figure 54. Europe Aprepitant Sales Market Share by Type (2018-2023)
Figure 55. Europe Aprepitant Sales Market Share by Application (2018-2023)
Figure 56. Germany Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Aprepitant Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Aprepitant Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Aprepitant Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Aprepitant Sales Market Share by Application (2018-2023)
Figure 65. Egypt Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Aprepitant Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Aprepitant in 2022
Figure 71. Manufacturing Process Analysis of Aprepitant
Figure 72. Industry Chain Structure of Aprepitant
Figure 73. Channels of Distribution
Figure 74. Global Aprepitant Sales Market Forecast by Region (2024-2029)
Figure 75. Global Aprepitant Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Aprepitant Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Aprepitant Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Aprepitant Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Aprepitant Revenue Market Share Forecast by Application (2024-2029)
